Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy with Envafolimab in Patients with Advanced or Metastatic Solid Tumors.
Phase 1
Active, not recruiting
- Conditions
- Advanced or Metastatic Solid Tumors
- Interventions
- Drug: KGX101- Cohort 3Drug: KGX101- Cohort -1Drug: KGX101- Cohort 2Drug: KGX101- Cohort 5Drug: KGX101- Cohort 4Drug: KGX101- Cohort 1
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Kangabio AUSTRALIA LTD PTY
- Target Recruit Count
- 54
- Registration Number
- NCT06074497
- Locations
- 🇦🇺
Pindara Private Hospital, Benowa, Queensland, Australia
🇦🇺Sunshine Coast University Private Hospital, Birtinya, Queensland, Australia
🇦🇺Peninsula & South Eastern Haematology and Oncology Group, Frankston, Victoria, Australia
News
No news found